ADRB2 and neuroblastoma: A study identified differentially expressed genes (DEG and DEM) in NB high-risk patients and nonhigh-risk patients through comprehensive bioinformatics analysis, and found that ADRB2 may affect the survival status of high-risk patients due to the regulation of miR-30a-5p [35].